Oxford Biomedica plc (LON:OXB)
571.00
-13.00 (-2.23%)
Jul 24, 2026, 5:12 PM GMT
Oxford Biomedica Revenue
In the year 2025, Oxford Biomedica had annual revenue of 168.74M GBP with 31.01% growth. Oxford Biomedica had revenue of 95.52M in the half year ending December 31, 2025, with 105.51% growth.
Revenue
168.74M
Revenue Growth
+31.01%
P/S Ratio
4.10
Revenue / Employee
172.71K
Employees
977
Market Cap
691.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 168.74M | 39.94M | 31.01% |
| Dec 31, 2024 | 128.80M | 39.26M | 43.84% |
| Dec 31, 2023 | 89.54M | -50.45M | -36.04% |
| Dec 31, 2022 | 139.99M | -2.81M | -1.97% |
| Dec 31, 2021 | 142.80M | 55.07M | 62.77% |
| Dec 31, 2020 | 87.73M | 23.67M | 36.95% |
| Dec 31, 2019 | 64.06M | -2.72M | -4.07% |
| Dec 31, 2018 | 66.78M | 29.19M | 77.65% |
| Dec 31, 2017 | 37.59M | 9.81M | 35.33% |
| Dec 31, 2016 | 27.78M | 11.87M | 74.59% |
| Dec 31, 2015 | 15.91M | 2.29M | 16.82% |
| Dec 31, 2014 | 13.62M | 8.24M | 153.36% |
| Dec 31, 2013 | 5.38M | -2.38M | -30.70% |
| Dec 31, 2012 | 7.76M | 38.00K | 0.49% |
| Dec 31, 2011 | 7.72M | -3.44M | -30.80% |
| Dec 31, 2010 | 11.15M | -7.97M | -41.67% |
| Dec 31, 2009 | 19.12M | 726.00K | 3.95% |
| Dec 31, 2008 | 18.39M | 11.18M | 154.80% |
| Dec 31, 2007 | 7.22M | 6.46M | 849.87% |
| Dec 31, 2006 | 760.00K | -64.00K | -7.77% |
| Dec 31, 2005 | 824.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genus | 672.00M |
| Oxford Nanopore Technologies | 223.90M |
| hVIVO | 49.66M |
| Bioventix | 12.54M |
| Scancell Holdings | 4.71M |
| PureTech Health | 3.46M |
| 4basebio | 1.69M |
| Ondine Biomedical | 1.43M |
Oxford Biomedica News
- 4 weeks ago - Oxford Biomedica price target lowered to 1,140 GBp at RBC Capital - TheFly
- 6 weeks ago - Oxford Biomedica Slides: Investor presentation - Filings
- 4 months ago - Oxford Biomedica Earnings Call Transcript: H2 2025 - Transcripts
- 4 months ago - Oxford Biomedica Annual report: H2 2025 - Filings
- 4 months ago - Oxford Biomedica Annual report: H2 2025 - Filings
- 4 months ago - Oxford Biomedica Slides: H2 2025 - Filings
- 4 months ago - Oxford Biomedica resumed with a Buy at Jefferies - TheFly
- 5 months ago - EQT backs out of takeover bid for UK's Oxford Biomedica - Reuters